Erratum: By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy

Alessandro Giammona, Adriana Cordova, Rosachiara Carollo, Flora Iovino, Giorgio Stassi, Matilde Todaro, Laura Rosa Mangiapane, Maurizio Callari, Marilisa Cargnelutti, Filippo Montemurro, Daniela Cimino, Annalisa Petrelli, Daniela Taverna, Maria Grazia Daidone, Silvia Giordano, Daniela Cimino, Silvia Giordano

Risultato della ricerca: Articlepeer review

Abstract

This article has been corrected: Due to errors in image assembly, the flow cytometry profiles depicting the isotype matched control (IMC) for CD49f on both scramble (scr) and miR-100 reported in Figure 6 are incorrect. Additionally, we noticed that the IMC reported for CD24 and CD10 in miR-100 are the same. Being both CD24 allophycocianin (APC) and CD10 APC IgG1, they should have the same IMC, as already reported. The corrected Figure 6 is shown below. The authors declare that these corrections do not change the results or conclusions of this paper.
Lingua originaleEnglish
pagine (da-a)5003-5004
Numero di pagine2
RivistaOncotarget
Volume10
Stato di pubblicazionePublished - 2019

All Science Journal Classification (ASJC) codes

  • Oncology

Fingerprint Entra nei temi di ricerca di 'Erratum: By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy'. Insieme formano una fingerprint unica.

Cita questo